GLP-1 receptor agonists significantly improve metabolic outcomes in type 2 diabetes patients, with notable reductions in HbA1c, body weight, and body fat. External eating behavior may predict greater ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback